Sign inJoin waitlistJoin the waitlist

Elizabeth Eklund

Johanna Dobe Professor of Hematology and Oncology · McGaw Medical Center of Northwestern University

Credentials: · · · ·

History

McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

Indiana University School of Medicine
1990–1991
Internal Medicine
Mayo Clinic College of Medicine and Science
1985–1988
Rush Medical College
1979–1983

Research

PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression
Journal of Biological Chemistry · 1998 · First of 3 authors · 140 citations
Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox…
The Journal of Immunology · 1999 · First of 2 authors · Corresponding · 101 citations
Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors
Journal of Biological Chemistry · 2002 · 91 citations

Leonidas Platanias
35 papers
LB
Ling Bei
25 papers · 14 as a resident
Jessica Altman
12 papers
CZ
Chunliu Zhu
7 papers
Chirag Shah
5 papers · 2 as a fellow
Belinda Sun
4 papers
Kathleen Sakamoto
4 papers
Peng Ji
4 papers
Theodore Gabig
4 papers
Amit Verma
3 papers
HB
Howard Boswell
3 papers
Irum Khan
3 papers

Grants

In Chronic Myeloid Leukemia, Persistence of Leukemia Stem Cells During Tyrosine Kinase Inhibitor Treatment Is Influenced by Interaction with αβT Cells
National Cancer Institute · R01
Contact PI · $954.4K · Northwestern University
2025–2030
Identifying Molecular Markers That Predict Relapse After Therapy Discontinuation in Chronic Myeloid Leukemia.
Department of Veterans Affairs · I01
Contact PI · Jesse Brown Va Medical Center
2019–2027
Molecular Mechanisms of Drug Resistance and Disease Progression in Acute Myeloid Leukemia.
Department of Veterans Affairs · I01
Contact PI · Jesse Brown Va Medical Center
2019–2027
The Robert H. Lurie Comprehensive Cancer Center
National Cancer Institute · P30
Project lead · $397.9K · Northwestern University
1997–2025

Clinical trials

Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
Principal investigator · Terminated · Phase 1
Northwestern University
2009–2013